SINGAPORE-- Cellular Biomedicine Group has bought chimeric antigen receptor T cell therapies from the Chinese PLA General Hospital in a deal valued at RMB12 million ($1.9 million) to be paid in three installments.
The market for drug-coated angioplasty balloons to treat peripheral artery disease has been bursting with activity in recent months. Boston Scientific joined the parade today, albeit as a distributor.
Medidata has signed a deal with Garmin to integrate the company's wearable vitals monitor into its cloud-based data tracking technology.
CrystalGenomics signed a sales and marketing deal with South Korea's Daewoong Pharmaceutical for the commercialization of Acelex (polmacoxib), granting the South Korean firm exclusive rights in country for the osteoarthritis treatment.
Exact Sciences is building on a previous collaboration with Mayo Clinic to develop tests for the gastrointestinal tract, riding high off last year's successes and expanding its offerings beyond colorectal cancer.
Sanofi inked a deal with the antibody discovery experts at Adimab, partnering up to generate a fleet of potential medicines.
With recent news of clinical trials for its low-cost HPV vaccine, the Serum Institute has already made waves in the world of Big Pharma. The India-based vaccinemaker is now gearing up to challenge the world's leading vaccinemakers in another area: pertussis.
3M pronounced last week that its Hollow Microstructure Transdermal System for home drug delivery by patients is available for licensing at the Drug Delivery Partnerships conference in Boca Raton, FL.
Astellas Pharma is getting a piece of the vaccine pie. The Japanese company is joining forces with U.S.-based Immunomic Therapeutics to develop the latter's vaccine to treat allergies caused by Japanese red cedar.
Ortho-Clinical Diagnostics has signed an exclusive deal worth up to $69 million with commercial-stage company Quotient to distribute and sell a blood transfusion diagnostics platform in development.